Emcure says it will continue growth momentum in FY22 by deepening product portfolio, digital focus

The privately held Pune-based company aims to first bring generic drugs to the market through the company’s own Ramp;D efforts and innovative molecules through licensing

from Moneycontrol Business News https://ift.tt/3vCY6bh